The HIV & Adolescence workshop is a highlight in my calendar every year. Unique because of its wholesale involvement of young people, state of the art keynote lectures, and engaging conversations involving young and older, clinician and non-clinicians, scientists, and advocates. It provides cutting-edge reviews of the latest innovation, science, and issues challenging young people in a world that is facing its 4th decade of battling HIV. If you need a dose of information, activism, hope, and education all in one workshop please join!
The International Workshop on HIV & Adolescence strongly believes in the engagement and inclusion of young people in the workshop.
We are pleased to waive the registration fee for all delegates that are 25 years of age and below.
Additionally, we offer a 50% discount on the registration fee for all delegates that are 30 years of age and below.
If you are eligible for this discount, please click the button below to submit your application.
For more information visit https://virology.eventsair.com/international-workshop-on-hiv-adolescence-2021/registration/Site/Register
Read moreThe University of the Western Cape, South Africa and SPaRCS partners invite all interested to this interactive webinar which seeks to sensitise a broader health systems and public health audience to pharmacoviligance (PV) and clinical trials oversight of medicines and vaccines. We will also be sharing information about the SPaRCS project and commence conversations for networking & collaboration within sub-Saharan African countries.
Keynote speaker: Dr Helen Ndagije (Director: Product Safety, National Drug Authority, Uganda)
*SPaRCS aims to strengthen pharmacovigilance (PV) systems and clinical trials oversight of National Regulatory Authorities (NRAs) in Namibia, South Africa, Eswatini and Zimbabwe.
Date and Time: Wednesday, 12 May 2021, 14:00-15:30 South African Standard Time
Registration: https://uwc.zoom.us/meeting/register/tJMuc--hpj8sHdUCzMsh5fy_LZ6fKFw_DKg7
Further information: tpetersen@uwc.ac.za, Tamlin Petersen, School of Public Health, UWC
Read moreOn World Malaria Day 2021, EDCTP joins all partners in the ‘Zero Malaria – Draw the Line Against Malaria’ campaign towards the goal of malaria elimination. Towards malaria research & development, EDCTP has invested more than €150 million to support a portfolio of 64 research projects conducted by African-European consortia and research fellows in Africa.
These projects support the development of innovative products – diagnostics, drugs and vaccines – needed to manage, control and eliminate malaria. EDCTP funding progressed the development of the R21 vaccine that recently demonstrated greater than 75% protection in a recent phase II trial. The EDCTP malaria portfolio also includes studies on implementation of interventions and activities to strengthen health systems, essential to ensure successful roll-out of new and existing products, and to contribute to the malaria eradication agenda.
“We must not waver in our efforts to control and steadily move towards malaria eradication, despite the COVID-19 pandemic and other challenges. The recent exciting results from the clinical development of the R21 malaria vaccine in Burkina Faso bring us a step closer to a highly effective malaria vaccine. We remain committed to support the development of new and improved products for the diagnosis, prevention and treatment, as well as product-focused implementation research to ensure that these products reach the populations that need them most.”
Dr Michael Makanga, EDCTP Executive Director
For more about EDCTP funded malaria projects visit https://www.edctp.org/news/world-malaria-day-2021/
Read moreSafety, Efficacy, Uptake and Equitable Access
Multiple COVID-19 vaccines are now approved for use and a global vaccination effort is underway.
To receive an update on the latest vaccine developments and the implementation of vaccination strategies, join the second edition of our virtual series on COVID-19 vaccines with topics to include vaccine efficacy and safety concerning real-world data. World experts will discuss new diagnostic tools to detect emergent SARS-CoV-2 variants and measure protection against infection and its durability.
Interactive lectures will dive into the prospects of vaccine development, including novel vaccine targets, and tackling vaccine hesitance in vulnerable populations, among other burning questions.
For more information visit https://virology.eventsair.com/covid-19-vaccineworkshop/registration/Site/Register